Clinical trial
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant…
NCT00192036 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00192036 |
|---|---|
| Title | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer |
| Official title | Multicenter Phase II Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | gemcitabine, cisplatin, radiation |
| Enrollment | 49 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 9, 2010 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: